1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page is a press release announcing the initiative; no application deadlines or open solicitation present.
"Autism Data Science Initiative (ADSI)" is currently closed and not accepting applications.
Autism Data Science Initiative (ADSI) is sponsored by National Institutes of Health (NIH). The Autism Data Science Initiative is a research effort to use large-scale data resources to explore factors contributing to the causes and rising prevalence of autism spectrum disorder. Projects will integrate, aggregate, and analyze existing data, generate targeted new data, and validate findings through independent replication hubs.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Autism Data Science Initiative | DPCPSI Autism Data Science Initiative Autism Data Science Initiative The Autism Data Science Initiative (ADSI) will bring together diverse data resources to explore possible contributors to the causes of autism. ADSI will also work to identify how existing treatments/interventions are used and better understand their outcomes to inform the design of future clinical studies.
This initiative will achieve these goals through four strategic aims: Support the integration of existing data resources with rigorous privacy protections for analysis by autism researchers. Identify gaps in available data and conduct data generation specifically to fill those gaps. Support analysis of the new data resources to explore the contribution of a variety of health and other factors to the causes of autism.
Support independent replication and validation of the initiative’s findings. ADSI funded 13 research projects. Learn about the funded projects .
Read the press release . For questions about the Autism Data Science Initiative, email: [email protected] This page last reviewed on
According to the current listing, eligibility includes: Research institutions and investigators. Confirm the full requirements in the official notice before applying.
The current listing shows more than $50,000,000 in awards. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was December 17, 2025, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Autism Data Science Initiative (ADSI) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article